UI Hospitals and Clinics

Lymphoma Program

Lymphoma refers to several types of blood cancers that develop in the lymph system—an important part the immune system that includes the spleen, liver, and bone marrow, plus the hundreds of lymph nodes located throughout the body.

There are many different types of lymphoma. It is unique form of cancer because it can begin almost anywhere in the body.

Treatments for lymphoma are changing rapidly, so it is important to seek the opinion of lymphoma experts with the most comprehensive care and expertise available:

  • The latest technologies and advanced screening and diagnostic techniques
  • A multidisciplinary team of experts who specialize in lymphoma care
  • Treatments and therapies tailored just for you
  • Follow-up care and emotional support you may need for "life after lymphoma"
  • It is our privilege—and our responsibility—to provide the care you expect and deserve. You can trust us to be with you every step of the way.

What sets us apart

  • Among the nation’s best. Holden Cancer Center is a National Institutes of Health-designated Comprehensive Cancer Center, one of only 45 such centers nationwide.
  • Team approach, targeted treatments. Our lymphoma experts—medical oncologists, radiation oncologists, and others—work together to offer advanced treatments and therapies tailored for you. Treatment plans may include:
    • Active surveillance, if your lymphoma is slow-growing or doesn’t cause symptoms
    • Chemotherapy, including liposomal drug delivery
    • Immunotherapy, including monoclonal antibody and cytokine therapy
    • Pinpointed, high-dose radiation therapy that minimizes damage to healthy tissue
    • Stem cell or bone marrow transplants
  • Experts dedicated solely to lymphoma. Our fellowship-trained medical oncologists and hematopathologists focus primarily on lymphoma. This leads to deeper understanding, greater expertise and, ultimately, better care for you.
  • Coordinated care, personal attention. Our multidisciplinary care team includes a nurse navigator who will help coordinate all aspects of your care. We also offer a range of counseling services, support groups, and more for you and your family.
  • Genetic counseling. Our genetics counselor may obtain and analyze your family history to calculate your risk for having a genetic mutation and counsel you on which genetic test, if any, to undergo.
  • Clinical trials. For you as a patient, this means access to potentially new medications, treatments, or imaging studies not yet widely available.
  • Lymphoma SPORE (Specialized Program of Research Excellence). The Lymphoma SPORE is a National Cancer Institute-funded research program based at Holden Comprehensive Cancer Center and Mayo Clinic.

Comprehensive Care With You in Mind

Holden Comprehensive Cancer Center is the only institution in Iowa—and one of only 45 nationwide—to be designated a Comprehensive Cancer Center by the National Cancer Institute (NCI). Of the approximately 1500 cancer centers and programs in the United States, NCI-designated Comprehensive Cancer Centers are rated in the top 4 percent nationally.

To be a “comprehensive” center means our medical teams have met strict guidelines in clinical, laboratory, and population-based research.

As members of an NCI-designated Comprehensive Cancer Center, our doctors, nurses, and staff are among the nation’s leaders in cancer research, education, prevention, and outreach. Our experience—and our expertise—guides the cancer care we provide to patients like you.

Team-Based Approach

We bring together experts from different areas of medicine to work together as a team called a multidisciplinary oncology group, focused on a specific cancer type, such as lymphoma.

This team of specialists—surgical oncologists, medical oncologists, radiation oncologists, radiologists, pathologists, pharmacists, genetics counselors, nurses, and others—works together to design a treatment plan that is tailored to your cancer and your specific treatment needs.

The Power of Clinical Trials

Clinical trials are research studies that test new treatments not yet available to the public. These new treatments have the potential to improve your quality of life or increase your chances of survival.

Many of our patients have the opportunity to participate in clinical trials led by Holden Cancer Center doctors or in collaboration with other cancer centers nationwide or the National Cancer Institute (NCI).

Our clinical trials for lymphoma patients

Burkitt lymphoma study
This study will help determine the safety and effectiveness of dose-adjusted, standard chemotherapy treatment—consisting of the drugs etoposide, prednisone, vincristine, cyclophosphamide, doxorubicin, and rituximab—in treating Burkitt lymphoma with fewer side effects than other standard chemotherapy treatments.
Lymphoma Molecular Epidemiologic Resource (LMER) and Lymphoma Epidemiology and Outcomes (LEO) Clinical Date and Tissue Sample Collection Project
This is a study to collect and store patients’ clinical information and tissue samples that will allow researchers to learn more about disorders of the lymph or blood system. The goal is to find causes and better treatments for these disorders.

Learn more about clinical research at Holden Comprehensive Cancer Center and search a database of current cancer clinical trials.

Support Our Mission

Our work is made possible in part by the support of donors through charitable giving. Friends of Holden Comprehensive Cancer Center can become partners in our efforts to control—and ultimately cure—cancer. Learn how you can help us make a difference for cancer patients.

Lymphoma Care Team

Medical Oncologists/Hematologists

Radiation Oncologists


Pediatric Oncologists/Hematologists

Medical Genetics

Advanced Registered Nurse Practitioner

Pediatric Advanced Registered Nurse Practitioner


  • Carol Homan, MD, PhD